Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lemanski

Showing results (281-290 of 311) with videos related to

Pageof 32
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2016
Factors associated with patient-reported cosmetic outcome in the Young Boost Breast TrialPatricia J A M Brouwers, Erik van Werkhoven, Harry Bartelink, et al.
Critical Reviews in Oncology/Hematology|May 16, 2009
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 casesB Cutuli, C Cohen-Solal Le-Nir, D Serin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2018
Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trialPatricia J A M Brouwers, Erik van Werkhoven, Harry Bartelink, et al.
The New England Journal of Medicine|November 22, 2023
High-Resolution and Noninvasive Fetal Exome ScreeningHarrison Brand, Christopher W Whelan, Michael Duyzend, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2026
Analysis of the relationship between body composition and the pharmacokinetics of panitumumab in the treatment of localized squamous cell carcinoma of the anus - An ancillary study of the FFCD0904 phase I and II trialSarah Lobet, David Ternant, Come Lepage, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trialVéronique Vendrely, Philippe Ronchin, Mathieu Minsat, et al.
The British Journal of Radiology|February 4, 2015
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancerV Pernin, L Belin, P Cottu, et al.
Oncotarget|April 13, 2018
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trialCéline Bourgier, Florence Castan, Olivier Riou, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2020
Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group DatabaseJean-Michel Hannoun-Levi, Jocelyn Gal, Erik Van Limbergen, et al.
Ebiomedicine|February 5, 2016
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French TrialDavid Azria, Olivier Riou, Florence Castan, et al.
Pageof 32

Showing results (281-290 of 311) with videos related to

Sort By:
Pageof 32
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2016
Factors associated with patient-reported cosmetic outcome in the Young Boost Breast TrialPatricia J A M Brouwers, Erik van Werkhoven, Harry Bartelink, et al.
Critical Reviews in Oncology/Hematology|May 16, 2009
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 casesB Cutuli, C Cohen-Solal Le-Nir, D Serin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2018
Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trialPatricia J A M Brouwers, Erik van Werkhoven, Harry Bartelink, et al.
The New England Journal of Medicine|November 22, 2023
High-Resolution and Noninvasive Fetal Exome ScreeningHarrison Brand, Christopher W Whelan, Michael Duyzend, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 22, 2026
Analysis of the relationship between body composition and the pharmacokinetics of panitumumab in the treatment of localized squamous cell carcinoma of the anus - An ancillary study of the FFCD0904 phase I and II trialSarah Lobet, David Ternant, Come Lepage, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trialVéronique Vendrely, Philippe Ronchin, Mathieu Minsat, et al.
The British Journal of Radiology|February 4, 2015
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancerV Pernin, L Belin, P Cottu, et al.
Oncotarget|April 13, 2018
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trialCéline Bourgier, Florence Castan, Olivier Riou, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2020
Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group DatabaseJean-Michel Hannoun-Levi, Jocelyn Gal, Erik Van Limbergen, et al.
Ebiomedicine|February 5, 2016
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French TrialDavid Azria, Olivier Riou, Florence Castan, et al.
Pageof 32